Business Acquisition [Axis]
Business Acquisition [Axis]
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other non-current liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Deferred tax assets, net
Deferred tax assets, net
Deferred Income Tax Assets, Net
Long term debt outstanding
Total
Long-Term Debt, Gross
Acquisition of a business, net of cash acquired
Payment To Acquire Assets, Net Of Cash Acquired
Payment To Acquire Assets, Net Of Cash Acquired
Tax provision (benefit) effect on fair value hedging activities
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Reclassification Adjustment, Tax
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Fair value of lines of credit
Lines of Credit, Fair Value Disclosure
2024
Long-Term Debt, Maturity, Year Two
Debt instrument, convertible, threshold consecutive trading days
Debt Instrument, Convertible, Threshold Consecutive Trading Days
Debt Instrument [Axis]
Debt Instrument [Axis]
Line of credit facility, maximum borrowing capacity
Line of Credit Facility, Maximum Borrowing Capacity
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Abstract]
Schedule of Cash and Cash Equivalents and Investments
Cash, Cash Equivalents and Investments [Table Text Block]
Xyrem
Xyrem [Member]
Xyrem [Member]
Computer software
Software and Software Development Costs [Member]
Employee compensation and benefits
Accrued Employee Benefits, Current
Financial Instruments [Domain]
Financial Instruments [Domain]
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Depreciation
Depreciation
Schedule of Indefinite-Lived Intangible Assets [Table]
Schedule of Indefinite-Lived Intangible Assets [Table]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Issuance of ordinary shares in conjunction with vesting of restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Interest rate (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Schedule of Foreign Exchange Gain (Losses) of Outstanding Derivatives
Derivative Instruments, Gain (Loss) [Table Text Block]
Share-based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
FDA stay of approval period
FDA Stay Of Approval Period
FDA Stay Of Approval Period
Other current assets
Other Current Assets [Member]
Additional paid-in capital
Additional paid-in capital
Additional Paid in Capital, Common Stock
Issuance of ordinary shares arising from the acquisition of GW and share-based payment - pre-combination service (in shares)
Stock Issued During Period, Shares, Acquisitions
Thereafter
Finite-Lived Intangible Asset, Expected Amortization, After Year Four
Finite-Lived Intangible Asset, Expected Amortization, After Year Four
Other non-cash transactions
Other Noncash Income (Expense)
Property, plant and equipment, net
Property, plant, and equipment and finance lease right-of-use asset, after accumulated depreciation and amortization, total
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Contractual coupon rate interest expense
Interest Expense, Debt, Contractual Coupon Rate
Interest Expense, Debt, Contractual Coupon Rate
Net income (loss)
Net income (loss)
Net income (loss)
Net Income (Loss) Attributable to Parent
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Ordinary shares (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Contingent Consideration by Type [Axis]
Contingent Consideration by Type [Axis]
Significant Risks and Uncertainties
Significant Risks And Uncertainties [Policy Text Block]
Describes risks and uncertainties related to the pharmaceutical industry.
Cumulative Effect, Period of Adoption [Axis]
Cumulative Effect, Period of Adoption [Axis]
Schedule of Maturities of Long-term Debt
Schedule of Maturities of Long-Term Debt [Table Text Block]
Subsequent Event Type [Axis]
Subsequent Event Type [Axis]
Teamsters and GEHA Lawsuits
Teamsters And GEHA Lawsuits [Member]
Teamsters And GEHA Lawsuits [Member]
Equity Component [Domain]
Equity Component [Domain]
Subsequent Event Type [Domain]
Subsequent Event Type [Domain]
Net income (loss) per ordinary share:
Earnings Per Share Reconciliation [Abstract]
Scenario [Axis]
Scenario [Axis]
Ownership [Axis]
Ownership [Axis]
Totals
Assets, Fair Value Disclosure
Total share-based compensation expense, net of tax
Share-Based Payment Arrangement, Expense, after Tax
Estimated Fair Value
Available-for-sale securities
Debt Securities, Available-for-Sale
Hedging Designation [Domain]
Hedging Designation [Domain]
Epidiolex/Epidyolex
Epidiolex/Epidyolex [Member]
Epidiolex/Epidyolex
Derivative Instrument [Axis]
Derivative Instrument [Axis]
Number of operating business segments
Number of Operating Segments
Statement of Cash Flows [Abstract]
Statement of Cash Flows [Abstract]
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Inputs, Level 1 [Member]
Other comprehensive loss:
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Award Type [Axis]
Award Type [Axis]
Contract Liabilities
Change In Contract With Customer, Liability [Roll Forward]
Change In Contract With Customer, Liability [Roll Forward]
Contingent Consideration Type [Domain]
Contingent Consideration Type [Domain]
Net cash provided by operating activities
Net Cash Provided by (Used in) Operating Activities
Inventory, step-up value
Inventory, Step-Up Value
Inventory, Step-Up Value
2026 Notes
Exchangeable Senior Notes Due 2026 [Member]
Exchangeable Senior Notes Due 2026 [Member]
Derivative asset
Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet
Derivative Asset
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule of RSU and PRSU Activity
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
Acquired in-process research and development assets
In Process Research and Development [Member]
Proceeds from sale of a business
Proceeds from Divestiture of Businesses
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Legal Entity [Axis]
Legal Entity [Axis]
Long-term debt, less current portion
Long-term debt, less current portion
Total long-term debt
Long-Term Debt, Excluding Current Maturities
Time deposits
Bank Time Deposits [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Geographical [Axis]
Geographical [Axis]
Investing activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
UK Finance Act 2021, change in statutory tax rate, income tax expense
U.K. Finance Act, Change In Tax Rate, Deferred Tax Liability, Income Tax Expense (Benefit)
U.K. Finance Act, Change In Tax Rate, Deferred Tax Liability, Income Tax Expense (Benefit)
Jazz Investments I Limited
Jazz Investments I Limited [Member]
Jazz Investments I Limited [Member]
Derivative instrument liabilities
Derivative Liability, Current
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Revolving Credit Facility
Revolving Credit Facility [Member]
Derivative Financial Instruments
Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Security Not Offset
Schedule of Property and Equipment
Property, Plant and Equipment [Table Text Block]
Document Type
Document Type
Total Neuroscience
Neuroscience [Member]
Neuroscience
Erwinaze/Erwinase
Erwinaze And Erwinase [Member]
Erwinaze And Erwinase [Member]
Debt
Long-Term Debt [Text Block]
Nippon Shinyaku
Nippon Shinyaku Co., Ltd. [Member]
Nippon Shinyaku Co., Ltd. [Member]
Three Customers
Three Customers [Member]
Three Customers
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Country Region
Country Region
Assets:
Assets, Fair Value Disclosure [Abstract]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Pro Forma
Pro Forma [Member]
Product and Service [Domain]
Product and Service [Domain]
Entity Shell Company
Entity Shell Company
Deferred tax expense (benefit)
Deferred Income Tax Expense (Benefit)
Accrued liabilities
Increase (Decrease) in Accrued Liabilities
Cost of product sales (excluding amortization of acquired developed technologies)
Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
Total costs related to goods produced and sold during the reporting period excluding amortization of acquired developed technologies and intangible asset impairment presented separately.
Concentration Risk [Table]
Concentration Risk [Table]
Schedule of Offsetting Liabilities
Offsetting Liabilities [Table Text Block]
Acquired developed technologies
Developed Technology Rights [Member]
Financial Instrument [Axis]
Financial Instrument [Axis]
2025
Long-Term Debt, Maturity, Year Three
Loss recognized in foreign exchange gain (loss)
Gain (Loss) on Fair Value Hedges Recognized in Earnings
Clinical trial accruals
Accrued Clinical Trial Liability
Accrued Clinical Trial Liability
Subsequent Event
Subsequent Event [Member]
Summary of a Reconciliation in Contract Liabilities from Contracts with Customer
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
Document Period End Date
Document Period End Date
Loss on fair value hedging activities reclassified from accumulated other comprehensive income (loss) to foreign exchange gain (loss), net of income tax benefit of $—, $—, $43 and $—, respectively
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification and Tax,
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification and Tax,
FDA recognition of orphan drug exclusivity, period
FDA Recognition Of Orphan Drug Exclusivity, Period
FDA Recognition Of Orphan Drug Exclusivity, Period
Debt Securities, Available-for-sale [Table]
Debt Securities, Available-for-Sale [Table]
Accounting Standards Update 2020-06
Accounting Standards Update 2020-06 [Member]
Derivative Instruments, Gain (Loss) [Table]
Derivative Instruments, Gain (Loss) [Table]
Components of Accumulated Other Comprehensive Loss
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Total assets
Assets
Debt Disclosure [Abstract]
Debt Disclosure [Abstract]
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Income Statement Location [Axis]
Income Statement Location [Axis]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Accrued liabilities
Total accrued liabilities
Accrued Liabilities, Current
Current portion of long-term debt
Less current portion
Long-Term Debt, Current Maturities
Net cash (used in) provided by financing activities
Net Cash Provided by (Used in) Financing Activities
2029 Senior Notes
Senior Notes Due 2029 [Member]
Senior Notes Due 2029
Accounting Policies [Abstract]
Accounting Policies [Abstract]
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note [Abstract]
Interest expense, debt
Interest Expense, Debt
Amounts reclassified from accumulated other comprehensive loss
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent
Line of Credit
Line of Credit [Member]
Upfront payment pending continued collaboration
Upfront Payment Pending Continued Collaboration
Upfront Payment Pending Continued Collaboration
Shareholders’ equity:
Stockholders' Equity Attributable to Parent [Abstract]
Cumulative Effect, Period of Adoption [Domain]
Cumulative Effect, Period of Adoption [Domain]
Net Income (Loss) per Ordinary Share
Earnings Per Share [Text Block]
Customer [Axis]
Customer [Axis]
Schedule of Weighted-Average Assumptions Used in Black-Scholes Option Pricing Model which was Used to Estimate Grant Date Fair Value per Share
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Xywav
Xywav [Member]
Xywav
Total Oxybate
Total Oxybate [Member]
Total Oxybate
Sumitomo
Sumitomo [Member]
Sumitomo
Certain Balance Sheet Items
Supplemental Balance Sheet Disclosures [Text Block]
Offsetting Liabilities [Line Items]
Offsetting Liabilities [Line Items]
Schedule of the Fair Value of Outstanding Derivatives
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Award Type [Domain]
Award Type [Domain]
Weighted-average period expected to be recognized
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Income Taxes [Table]
Income Tax Contingency [Table]
Computer equipment
Computer Equipment [Member]
Derivative Contract [Domain]
Derivative Contract [Domain]
Entity Registrant Name
Entity Registrant Name
Subsequent Events
Subsequent Events [Text Block]
Expected dividend yield (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Foreign exchange
Goodwill, Foreign Currency Translation Gain (Loss)
Offsetting Assets [Line Items]
Offsetting Assets [Line Items]
Milestone Payment
Milestone Payment [Member]
Milestone Payment
Foreign Currency Translation Adjustments
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Farrell Lawsuit And Levy Lawsuit
Farrell Lawsuit And Levy Lawsuit [Member]
Farrell Lawsuit And Levy Lawsuit
Entity Address, City or Town
Entity Address, City or Town
Net Unrealized Loss From Hedging Activities
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Operating expenses:
Operating Expenses [Abstract]
Basis of Presentation
Consolidation, Policy [Policy Text Block]
Minimum
Minimum [Member]
Debt instrument, convertible, number of shares per principal amount basis (in shares)
Debt Instrument, Convertible, Conversion Ratio
Statement of Financial Position [Abstract]
Statement of Financial Position [Abstract]
Emerging Growth Company
Entity Emerging Growth Company
Raw materials
Inventory, Raw Materials, Net of Reserves
Unrealized loss on cash flow hedging activities, net of income tax benefit of $—, $—, $— and $2, respectively
Loss recognized in accumulated other comprehensive income (loss), net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
Performance-Based Restricted Stock Units (PRSUs)
Performance-Based Restricted Stock Units (RSUs) [Member]
Performance-Based Restricted Stock Units (RSUs)
Debt issuance costs
Debt Issuance Costs, Net
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Accounting Standards Update [Axis]
Accounting Standards Update [Axis]
Fair Value Measurement
Fair Value Disclosures [Text Block]
Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Trading Symbol
Trading Symbol
Entity File Number
Entity File Number
Exchangeable Senior Notes
Convertible Debt Securities [Member]
One-Time Payments
One-Time Payments [Member]
One-Time Payments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss) [Line Items]
2026
Finite-Lived Intangible Asset, Expected Amortization, Year Four
Deferred revenue, non-current
Contract with Customer, Liability, Noncurrent
Accrued interest
Interest Payable, Current
2021 Credit Agreement, Euro Term Loan
Two Thousand Twenty One Credit Agreement, Euro Term Loan [Member]
Two Thousand Twenty One Credit Agreement, Euro Term Loan
Disposal Group Classification [Axis]
Disposal Group Classification [Axis]
RSUs granted (in shares)
PRSUs granted (in thousands)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Restricted Stock Units (RSUs)
Restricted Stock Units (RSUs) [Member]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
All other
Other Countries [Member]
Other Countries [Member]
Accounts payable
Increase (Decrease) in Accounts Payable
Tiered royalty fees percentage, maximum
Tiered Royalty Fees Percentage, Maximum
Tiered Royalty Fees Percentage, Maximum
Percentage of gross accounts receivable (as a percent)
Percentage of total revenues (as a percent)
Concentration Risk, Percentage
Subsequent Events [Abstract]
Subsequent Events [Abstract]
Derivative liabilities
Derivative Liability [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Non-voting euro deferred shares
Nonvoting Euro Deferred Shares
Shares issued to satisfy statutory minimum of Euro-denominated share capital required for a public limited company incorporated in Ireland.
Payment for debt extinguishment or debt prepayment cost
Payment for Debt Extinguishment or Debt Prepayment Cost
Finished goods
Inventory, Finished Goods, Net of Reserves
Credit Facility [Domain]
Credit Facility [Domain]
Intangible assets, gross
Intangible Assets, Gross (Excluding Goodwill)
Intangible asset amortization
Intangible asset amortization
Amortization of Intangible Assets
Schedule of Gross Carrying Amount of Goodwill
Schedule of Goodwill [Table Text Block]
Basic (in dollars per share)
Earnings Per Share, Basic
Employee equity incentive and purchase plans
Equity Unit Purchase Agreements [Member]
Zepzelca
Zepzelca [Member]
Zepzelca
2021 Credit Agreement, Revolving Credit Facility
Two Thousand Twenty One Credit Agreement, Revolving Credit Facility [Member]
Two Thousand Twenty One Credit Agreement, Revolving Credit Facility
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Payments for repurchase of Exchangeable Senior Notes, due 2021
Repayments of Convertible Debt
Counterparty Name [Domain]
Counterparty Name [Domain]
Indefinite-lived Intangible Assets [Axis]
Indefinite-Lived Intangible Assets [Axis]
Total shareholders’ equity
Beginning balance
Ending balance
Stockholders' Equity Attributable to Parent
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Prepaid expenses
Prepaid Expense, Current
Summary Of Deferred Revenue [Table]
Summary Of Deferred Revenue [Table]
Summary Of Deferred Revenue [Table]
Ownership [Domain]
Ownership [Domain]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) [Line Items]
Entity Interactive Data Current
Entity Interactive Data Current
Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Fair Value, by Balance Sheet Grouping [Table]
Fair Value, by Balance Sheet Grouping [Table]
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Number of countries product approved and commercialized
Number Of Countries Product Approved And Commercialized
Number Of Countries Product Approved And Commercialized
Changes in assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
2025
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Money market funds
Money Market Funds [Member]
Total Oncology
Oncology [Member]
Oncology
Land and buildings
Land and Building [Member]
Retained Earnings
Retained Earnings [Member]
Upfront payment received
Disposal Group, Not Discontinued Operation, Upfront Payment Received
Disposal Group, Not Discontinued Operation, Upfront Payment Received
Ordinary Shares
Common Stock [Member]
Schedule of Share-Based Compensation Expense Related to Share Options, RSUs , PRSU's and Grants Under ESPP
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Other comprehensive loss
Other comprehensive loss
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Cardinal
Cardinal Health Inc. [Member]
Cardinal Health Inc.
Other comprehensive loss before reclassifications
OCI, before Reclassifications, Net of Tax, Attributable to Parent
Share repurchases
Payments for Repurchase of Common Stock
Statement [Table]
Statement [Table]
Effective interest rate (as a percent)
Debt Instrument, Interest Rate, Effective Percentage
Issuance of ordinary shares arising from the acquisition of GW and share-based payment - pre-combination service
Stock Issued During Period, Value, Acquisitions
Document Quarterly Report
Document Quarterly Report
Liability derivatives
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement
Outside United States
Outside United States [Member]
Outside United States
Furniture and fixtures
Furniture and Fixtures [Member]
Current assets:
Assets, Current [Abstract]
Operating lease liabilities, less current portion
Operating Lease, Liability, Noncurrent
Disposal Group, Held-for-sale, Not Discontinued Operations
Disposal Group, Held-for-sale, Not Discontinued Operations [Member]
ESSDS
Express Scripts [Member]
Express Scripts 1 [Member]
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Acquired in-process research and development
Research and Development Asset Acquired Other than Through Business Combination, Written-off
Senior Secured Debt
Senior Secured Debt [Member]
Senior Secured Debt
Acquired in-process research and development assets
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Leasehold improvements
Leasehold Improvements [Member]
Retained earnings
Retained earnings
Retained Earnings (Accumulated Deficit)
Disposal Group Name [Axis]
Disposal Group Name [Axis]
Accounts receivable, net of allowances
Accounts Receivable, after Allowance for Credit Loss, Current
Schedule of Finite-Lived Intangible Assets [Table]
Schedule of Finite-Lived Intangible Assets [Table]
Fair value of exchangeable senior notes
Convertible Debt, Fair Value Disclosures
Equity Components [Axis]
Equity Components [Axis]
Scenario [Domain]
Scenario [Domain]
Trademarks
Trademarks [Member]
Recurring
Fair Value, Recurring [Member]
Litigation Case [Domain]
Litigation Case [Domain]
Derivative Financial Instruments
Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Security Not Offset
Loss recognized in accumulated other comprehensive income (loss), net of tax
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Tax and Reclassification Adjustment
Interest expense, net
Interest Income (Expense), Nonoperating, Net
Document Fiscal Year Focus
Document Fiscal Year Focus
Operating activities
Net Cash Provided by (Used in) Operating Activities [Abstract]
Current portion of lease liabilities
Lease, Liability, Current
Lease, Liability, Current
Statement [Line Items]
Statement [Line Items]
Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets [Line Items]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Milestone payments
Gross Carrying Amount
Finite-Lived Intangible Assets, Gross
Selling, general and administrative
Selling, General and Administrative Expense
Schedule of ASU 2020-06 Adoption Impact on Condensed Balance Sheet
Condensed Balance Sheet [Table Text Block]
Loss Contingencies [Table]
Loss Contingencies [Table]
Defitelio/defibrotide
Defitelio/Defibrotide [Member]
Defitelio/Defibrotide [Member]
Accrued royalties
Accrued Royalties, Current
Gross Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Operating lease assets
Operating Lease, Right-of-Use Asset
Accumulated Other Comprehensive Loss
Total Accumulated Other Comprehensive Loss
AOCI Attributable to Parent [Member]
Net income (loss) per ordinary share:
Earnings Loss Per Ordinary Share [Abstract]
Earnings Loss Per Ordinary Share
Other
Other Products [Member]
Other Products [Member]
Document Transition Report
Document Transition Report
Local Phone Number
Local Phone Number
Operating lease assets
Increase (Decrease) In Operating Lease Assets
Increase (Decrease) In Operating Lease Assets
Income from operations
Operating Income (Loss)
Inventories
Increase (Decrease) in Inventories
Net liability fair value
Derivative, Fair Value, Net
Adoption of New Accounting Standards and Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Equity securities without readily determinable fair value
Equity Securities without Readily Determinable Fair Value, Amount
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Goodwill
Goodwill, beginning of period
Goodwill, end of period
Goodwill
Rebates and other sales deductions
Accrued Rebates And Other Sales Deductions
Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and other sales deductions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Financing and Payment [Line Items]
Summary Of Deferred Revenue [Line Items]
[Line Items] for Summary Of Deferred Revenue [Table]
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block]
Income tax expense (benefit)
Income Tax Expense (Benefit)
Geographical [Domain]
Geographical [Domain]
Deferred tax liabilities, net
Deferred Income Tax Liabilities, Net
Income Statement [Abstract]
Income Statement [Abstract]
Shares underlying options granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Hedging Relationship [Axis]
Hedging Relationship [Axis]
Revenue, performance obligation, description of timing
Revenue, Performance Obligation, Description of Timing
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Balance Sheet Location [Domain]
Balance Sheet Location [Domain]
Axsome
Axsome [Member]
Axsome
Document Fiscal period Focus
Document Fiscal Period Focus
Cumulative Effect, Period of Adoption, Adjusted Balance
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Non-voting Euro Deferred
Euro Deferred Shares [Member]
Euro Deferred Shares [Member]
Derivative [Line Items]
Derivative [Line Items]
Weighted-average ordinary shares used in per share calculations - diluted (in shares)
Weighted-average ordinary shares used in per share calculation - diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Cash Collateral Received (Pledged)
Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset
Derivative liabilities
Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet
Derivative Liability
Components of Inventories
Schedule of Inventory, Current [Table Text Block]
Achievement target, percentage of awards granted
Share-based Compensation Arrangement by Share-based Payment Award, Achievement Target, Percentage Of Awards Granted
Share-based Compensation Arrangement by Share-based Payment Award, Achievement Target, Percentage Of Awards Granted
Gross Amounts of Recognized Assets/ Liabilities
Derivative Liability, Subject to Master Netting Arrangement, before Offset
Expected term (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Gross Amounts Not Offset in the Consolidated Balance Sheet
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction [Abstract]
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Gross accounts receivable
Accounts Receivable [Member]
Schedule of Other Comprehensive Income (Losses) on Derivative Instruments
Schedule Of Fair Value Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Schedule Of Fair Value Hedges Included In Accumulated Other Comprehensive Income (Loss)
Investments
Investments
Ordinary shares
Common Stock, Value, Issued
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Business Acquisition, Acquiree [Domain]
Business Acquisition, Acquiree [Domain]
Grant date fair value (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Debt instrument, convertible, conversion price (in dollars per share)
Debt Instrument, Convertible, Conversion Price
Schedule of Weighted-Average Ordinary Shares Excluded from Computation of Diluted Net Income (Loss) per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Other Comprehensive Income (Losses) on Derivative Instruments
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Convertible Debt
Convertible Debt
Convertible Debt [Member]
Provision for losses on accounts receivable and inventory
Provision For Losses On Accounts Receivable And Inventory
Amount of the current period expense charged against operations (1) for the purpose of reducing receivables to an amount that approximates their net realizable value and (2) the charge to cost of goods sold that represents the reduction off the carrying amount of inventory, generally attributable to obsolescence or market conditions.
Acquisition accounting inventory fair value step-up adjustment
Inventory Step-Up Value Adjustment
The noncash expense recognized in the current period from the amortization of acquired inventory written up to fair value in purchase accounting
Sativex® (nabiximols)
Sativex [Member]
Sativex
Impairment of our acquired IPR&D asset
Impairment of Intangible Assets, Finite-Lived
Cash and cash equivalents, at beginning of period
Cash and cash equivalents, at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Foreign currency translation adjustments
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Accrued milestones
Accrued Milestones
Accrued Milestones
Sunosi
Sunosi [Member]
Sunosi [Member]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Current liabilities:
Liabilities, Current [Abstract]
Payment terms, range
Revenue, Performance Obligation, Payment Terms
Revenue, Performance Obligation, Payment Terms
Foreign exchange forward contracts
Foreign Exchange Forward [Member]
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Deferred revenue
Contract with Customer, Liability, Current
Tiered royalty fees percentage, minimum
Tiered Royalty Fees Percentage, Minimum
Tiered Royalty Fees Percentage, Minimum
Inventory-related accruals
Accrued Inventory Related Liabilities
Accrued Inventory Related Liabilities
Tax benefit effect on cash flow hedging activities
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
Foreign exchange gain (loss)
Foreign Currency Transaction Gain (Loss), before Tax
Income Statement Location [Domain]
Income Statement Location [Domain]
Derivative assets
Derivative Asset [Abstract]
Cash Flow Hedges
Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amendment Flag
Amendment Flag
Net cash used in investing activities
Net Cash Provided by (Used in) Investing Activities
Debt instrument, face amount
Debt Instrument, Face Amount
Class action lawsuits filed
Loss Contingency, New Claims Filed, Number
Issuance of ordinary shares under employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Total comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Litigation Case [Axis]
Litigation Case [Axis]
Proceeds from employee equity incentive and purchase plans
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised
Schedule of Gross Carrying Amounts and Net Book Values of Intangible Assets
Schedule Of Finite Lived And Indefinite Lived Intangible Assets [Table Text Block]
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance, both finite life and indefinite life, by major class.
Construction-in-progress
Construction in Progress [Member]
Gross Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Entity Current Reporting Status
Entity Current Reporting Status
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Abstract]
Other non-current assets
Other Assets, Noncurrent
Cross-currency interest rate contracts
Cross Currency Interest Rate Contract [Member]
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Table]
Sales return reserve
Sales Return Reserve
Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales returns reserve. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Net proceeds from issuance of Senior Secured Notes, due 2029
Proceeds from Issuance of Senior Long-Term Debt
Issuance of ordinary shares under employee stock purchase plan (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Counterparty Name [Axis]
Counterparty Name [Axis]
Derivative [Table]
Derivative [Table]
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Table]
Selling and marketing accruals
Accrued Marketing Costs, Current
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Net Amount
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction
Effect of exchange rates on cash and cash equivalents
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Schedule of Estimated Future Amortization Costs
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Other non-current assets
Increase (Decrease) in Other Noncurrent Assets
Employee Stock Option
Share-Based Payment Arrangement, Option [Member]
Volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Product sales, net
Product sales, net
Product And Services, Product Sales Net Of Deductions [Member]
Product And Services, Product Sales Net Of Deductions [Member]
Loss on disposal
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
Net proceeds from issuance of borrowings under credit agreement
Proceeds From Issuance Of Term Loan
Proceeds From Issuance Of Term Loan
Issuance of ordinary shares in conjunction with exercise of share options
Stock Issued During Period, Value, Stock Options Exercised
Total debt
Long-Term Debt
Balance Sheet Location [Axis]
Balance Sheet Location [Axis]
The Company and Summary of Significant Accounting Policies
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]
Schedule of Weighted Average Assumptions for Fair Values of Stock Options[Line Items]
Schedule Of Weighted Average Assumptions For Fair Values Of Stock Options [Line Items]
Schedule of Weighted Average Assumptions for Fair Values of Stock Options[Line Items]
Potential Milestone Payment
Potential Milestone Payment [Member]
Potential Milestone Payment
Statement of Comprehensive Income [Abstract]
Statement of Comprehensive Income [Abstract]
Maximum
Maximum [Member]
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Schedule of Business Acquisitions, by Acquisition [Table]
Schedule of Business Acquisitions, by Acquisition [Table]
Shares repurchased
Stock Repurchased and Retired During Period, Value
Cash and cash equivalents
Cash and Cash Equivalents
Cash and Cash Equivalents, at Carrying Value
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
Total current assets
Assets, Current
Derivatives designated as hedging instruments
Designated as Hedging Instrument [Member]
Income taxes payable
Taxes Payable, Current
Tax benefit effect on fair value hedging activities reclassified
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
Contract revenue recognized
Amount recognized within royalties and contract revenues
Contract with Customer, Liability, Revenue Recognized
Business Acquisition [Line Items]
Business Acquisition [Line Items]
Smaller Reporting Company
Entity Small Business
Beginning balance (in shares)
Ending balance (in shares)
Shares, Outstanding
Measurement Frequency [Domain]
Measurement Frequency [Domain]
Shareholders' Equity
Stockholders' Equity Note Disclosure [Text Block]
Revenues:
Revenues [Abstract]
Total
Finite-Lived Intangible Assets, Net
Debt instrument, convertible, threshold trading days
Debt Instrument, Convertible, Threshold Trading Days
Unrecognized compensation cost related to unvested stock option, RSUs, and PRSUs
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Numerator:
Numerator [Abstract]
Numerator [Abstract]
Lupin Lawsuit
Lupin Lawsuit [Member]
Lupin Lawsuit
Infringed patents suit, number of patents
Infringed Patents Suit, Number Of Patents
Infringed Patents Suit, Number Of Patents
Income tax benefit from share-based compensation expense
Share-Based Payment Arrangement, Expense, Tax Benefit
Acquired in-process research and development
Payments to Acquire In Process Research and Development Other Than Through Business Combination
Payments to Acquire In Process Research and Development Other Than Through Business Combination
Shares repurchased (in shares)
Stock Repurchased and Retired During Period, Shares
Tax benefit effect on fair value hedging activities
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification, Tax
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification, Tax
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Title of 12(b) Security
Title of 12(b) Security
Unrealized gain (loss) on fair value hedging activities, net of income tax provision (benefit) of $—, $28, $— and ($97), respectively
Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax
Certain Balance Sheet Items [Abstract]
Certain Balance Sheet Items [Abstract]
Certain Balance Sheet Items [Abstract]
Proceeds from maturity of investments
Proceeds from Sale, Maturity and Collection of Investments
Fair value of secured debt
Notes Payable, Fair Value Disclosure
Total operating expenses
Costs and Expenses
Subsequent Event [Line Items]
Subsequent Event [Line Items]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Business Combination and Asset Acquisition [Abstract]
Income Taxes [Line Items]
Income Tax Contingency [Line Items]
Selling, general and administrative
Selling, General and Administrative Expenses [Member]
Investments, Debt and Equity Securities [Abstract]
Investments, Debt and Equity Securities [Abstract]
Entity Address, Country
Entity Address, Country
2024
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Loss recognized in foreign exchange gain (loss)
Derivative, Gain (Loss) on Derivative, Net
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities and Equity [Abstract]
Loss reclassified from accumulated other comprehensive income (loss) to foreign exchange gain (loss), net of tax
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Recurring and Nonrecurring [Table]
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost
Acquisition of intangible assets
Payments to Acquire Intangible Assets
Cash and Available-for-Sale Securities
Cash, Cash Equivalents, and Marketable Securities [Text Block]
2022 (remainder)
Long-Term Debt, Maturity, Remainder of Fiscal Year
2024 Notes
Exchangeable Senior Notes Due 2024 [Member]
Exchangeable Senior Notes Due 2024 [Member]
Inventories
Total inventories
Inventory, Net
Accounts payable
Accounts Payable, Current
2021 Credit Agreement, Dollar Term Loan
Two Thousand Twenty One Credit Agreement, Dollar Term Loan [Member]
Two Thousand Twenty One Credit Agreement, Dollar Term Loan
Schedule of Weighted Average Assumptions for Fair Values of Stock Options [Table]
Schedule Of Weighted Average Assumptions For Fair Values Of Stock Options [Table]
Schedule of Weighted Average Assumptions for Fair Values of Stock Options [Table]
Capital Redemption Reserve
Capital Redemption Reserve [Member]
Capital Redemption Reserve [Member]
Unamortized discount - equity component
Debt Instrument, Unamortized Discount
Debt instrument, convertible, threshold percentage of stock price trigger
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger
2026
Long-Term Debt, Maturity, Year Four
Less accumulated depreciation and amortization
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization
Hedging Relationship [Domain]
Hedging Relationship [Domain]
Hedging Designation [Axis]
Hedging Designation [Axis]
Offsetting Assets [Table]
Offsetting Assets [Table]
Entity Filer Category
Entity Filer Category
Gross Amounts Offset in the Consolidated Balance Sheet
Derivative Asset, Subject to Master Netting Arrangement, Liability Offset
Weighted-average ordinary shares used in per share calculations - basic (in shares)
Weighted-average ordinary shares used in per share calculation - basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Non-cash interest expense
Noncash Interest Expense
Noncash Interest Expense
United States
UNITED STATES
Disposal Groups, Including Discontinued Operations [Table]
Disposal Groups, Including Discontinued Operations [Table]
Asset derivatives
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement
Deferred charge for income taxes on intercompany profit
Deferred Tax, Intercompany Profit, Current
Deferred Tax, Intercompany Profit, Current
GW Pharmaceuticals plc
GW Pharmaceuticals plc [Member]
GW Pharmaceuticals plc
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Total share-based compensation expense, pre-tax
Share-Based Payment Arrangement, Expense
Commitments and contingencies (Note 10)
Commitments and Contingencies
Security Exchange Name
Security Exchange Name
Loss on disposal of a business
Gain (Loss) on Disposition of Assets
Infringed patents suit, other party counterclaim, number of patents requested to be delisted
Infringed Patents Suit, Other Party Counterclaim, Number Of Patents Requested To Be Delisted
Infringed Patents Suit, Other Party Counterclaim, Number Of Patents Requested To Be Delisted
Remaining Weighted- Average Useful Life (In years)
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life
Offsetting Liabilities [Table]
Offsetting Liabilities [Table]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notional amount
Derivative, Notional Amount
Loss on cash flow hedging activities reclassified from accumulated other comprehensive income (loss) to interest expense, net of income tax benefit of $—, $22, $— and $355, respectively
Gain reclassified from accumulated other comprehensive income (loss) to interest expense, net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax
Term Loan
Term Loan [Member]
Term Loan [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Total revenues
Revenue from Contract with Customer, Excluding Assessed Tax
Income taxes payable
Increase (Decrease) in Income Taxes Payable
Manufacturing contracts
Manufacturing Contracts [Member]
Manufacturing Contracts [Member]
Cover [Abstract]
Cover [Abstract]
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-Term Debt Instruments [Table]
Upfront Payments
Upfront Payments [Member]
Upfront Payments [Member]
Loss before income tax expense (benefit) and equity in loss (gain) of investees
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
Total potential collaboration payments
Total Potential Collaboration Payments
Total Potential Collaboration Payments
Rylaze
Rylaze [Member]
Rylaze
Share-Based Compensation
Share-Based Payment Arrangement [Text Block]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Work in process
Inventory, Work in Process, Net of Reserves
Revenues
Revenue from Contract with Customer [Text Block]
Schedule of Other Current Assets
Schedule of Other Current Assets [Table Text Block]
Forecast
Forecast [Member]
Goodwill allocated to divestiture of Sunosi
Goodwill, Written off Related to Sale of Business Unit
Vyxeos
Vyxeos [Member]
Vyxeos [Member]
Payment of employee withholding taxes related to share-based awards
Payment, Tax Withholding, Share-Based Payment Arrangement
Total liabilities and shareholders’ equity
Liabilities and Equity
Term (in years)
Debt Instrument, Term
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
Goodwill [Roll Forward]
Goodwill [Roll Forward]
Long-term Debt, Type [Axis]
Long-Term Debt, Type [Axis]
Dilutive effect of employee equity incentive and purchase plans (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements
Derivatives not designated as hedging instruments
Not Designated as Hedging Instrument [Member]
Disposal Group Name [Domain]
Disposal Group Name [Domain]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Significant Other Observable Inputs (Level 2)
Fair Value, Inputs, Level 2 [Member]
Capital redemption reserve
Capital Redemption Reserve
Capital redemption reserve created under Irish company law to preserve permanent capital in the company.
Gross Amounts Not Offset in the Consolidated Balance Sheet
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction [Abstract]
Acquisition of investments
Payments to Acquire Investments
Current Fiscal Year End Date
Current Fiscal Year End Date
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets [Line Items]
Diluted (in dollars per share)
Diluted (in dollars per share)
Earnings Per Share, Diluted
Intangible assets, net
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Inventory [Line Items]
Inventory [Line Items]
Vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Percentage of ownership (as a percent)
Noncontrolling Interest, Ownership Percentage by Parent
Share-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Total current liabilities
Liabilities, Current
Range of risk-free rates, minimum (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Other current assets
Other current assets
Other Assets, Current
Inventory, Current [Table]
Inventory, Current [Table]
Customer concentration risk
Customer Concentration Risk [Member]
Disposition and License Agreements
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment [Member]
Gross Amounts Offset in the Consolidated Balance Sheet
Derivative Liability, Subject to Master Netting Arrangement, Asset Offset
Range of risk-free rates, maximum (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Total Revenues
Revenue from Contract with Customer Benchmark [Member]
Gross Amounts of Recognized Assets/ Liabilities
Derivative Asset, Subject to Master Netting Arrangement, before Offset
Summary of Revenues from Customers Representing More Than 10% of Total Revenues
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
Entity Address, Address Line Two
Entity Address, Address Line Two
Entity Address, Address Line One
Entity Address, Address Line One
Net Amount
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction
Beginning balance
Ending balance
Contract with Customer, Liability
Product and Service [Axis]
Product and Service [Axis]
Europe
Europe [Member]
Cash Collateral Received (Pledged)
Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Abstract]
Interest expense
Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Denominator:
Denominator [Abstract]
Denominator [Abstract]
Available-for-sale securities:
Debt Securities, Available-for-Sale [Abstract]
Credit Facility [Axis]
Credit Facility [Axis]
Schedule of Accrued Liabilities
Schedule of Accrued Liabilities [Table Text Block]
Inventories
Inventory Disclosure [Text Block]
Schedule of Long-term Debt
Schedule of Long-Term Debt Instruments [Table Text Block]
Manufacturing equipment and machinery
Machinery and Equipment [Member]
Subsequent Event [Table]
Subsequent Event [Table]
Inventory Disclosure [Abstract]
Inventory Disclosure [Abstract]
Entity Tax Identification Number
Entity Tax Identification Number
Unamortized - debt issuance costs
Unamortized Debt Issuance Expense
Derivatives, Fair Value [Line Items]
Derivatives, Fair Value [Line Items]
Thereafter
Long-Term Debt, Maturity, After Year Four
Long-Term Debt, Maturity, After Year Four
Royalties and contract revenues
Royalties and contract revenues
Product And Services, Royalties And Contract Revenue [Member]
Product And Services, Royalties And Contract Revenue [Member]
Summary of Disaggregation of Revenue
Disaggregation of Revenue [Table Text Block]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Abstract]
2022 (remainder)
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Number of license, development and commercialization agreements
Licensing Agreement, Number Of Agreements
Licensing Agreement, Number Of Agreements
Cash
Cash [Member]
Werewolf
Werewolf [Member]
Werewolf
Research and development
Research and Development Expense (Excluding Acquired in Process Cost)
Property, plant and equipment, gross and finance lease right out use asset before accumulated depreciation and amortization
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization
Other
Other Assets, Miscellaneous, Current
Net increase (decrease) in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Jazz Securities Designated Activity Company
Jazz Securities Designated Activity Company [Member]
Jazz Securities Designated Activity Company
Avadel Pharmaceuticals plc Lawsuit
Avadel Pharmaceuticals plc Lawsuit [Member]
Avadel Pharmaceuticals plc Lawsuit
Accrued liabilities
Accrued Liabilities [Member]
McKesson
McKesson Corporation [Member]
McKesson Corporation [Member]
Entity Central Index Key
Entity Central Index Key
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Interest income from available-for-sale securities
Investment Income, Interest
Repayments of long-term debt
Repayments of Secured Debt
Measurement Frequency [Axis]
Measurement Frequency [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Shares withheld for payment of employee's withholding tax liability
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Consideration transferred
Business Combination, Consideration Transferred
Concentrations of Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Other
Other Accrued Liabilities, Current
Entity [Domain]
Entity [Domain]
Accounting Standards Update [Domain]
Accounting Standards Update [Domain]
Operating lease liabilities, less current portion
Increase (Decrease) In Operating Lease Liabilities, Noncurrent
Increase (Decrease) In Operating Lease Liabilities, Noncurrent
City Area Code
City Area Code
Consulting and professional services
Accrued Professional Fees, Current
ASSETS
Assets [Abstract]
Deferred financing costs
Debt Issuance Costs, Noncurrent, Net
Long-term Debt, Type [Domain]
Long-Term Debt, Type [Domain]
Statement of Stockholders' Equity [Abstract]
Statement of Stockholders' Equity [Abstract]
Nominal Strike Price Options
Nominal Strike Price Options [Member]
Nominal Strike Price Options
Financing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Totals
Financial Liabilities Fair Value Disclosure
2023
Long-Term Debt, Maturity, Year One
Share-based compensation
Share-Based Payment Arrangement, Noncash Expense
Weighted-average grant date fair value (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Other non-current liabilities
Other Liabilities, Noncurrent
Interest rate contracts
Interest Rate Contract [Member]
Equity in loss (gain) of investees
Income (Loss) from Equity Method Investments
Disposal Group Classification [Domain]
Disposal Group Classification [Domain]
Purchases of property, plant and equipment
Payments to Acquire Property, Plant, and Equipment
Impairment charge
Asset Impairment Charges
Zymeworks
Zymeworks [Member]
Zymeworks
Research and development
Research and Development Expense [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Noncancelable purchase commitments due within one year
Purchase Commitment, Remaining Minimum Amount Committed
2023
Finite-Lived Intangible Asset, Expected Amortization, Year One
Schedule of Basic and Diluted Net Income (Loss) per Ordinary Share Computation
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Cost of product sales
Cost of Sales [Member]
Schedule of Offsetting Assets
Offsetting Assets [Table Text Block]
Customer [Domain]
Customer [Domain]
GW Litigation
GW Litigation [Member]
GW Litigation
Accrued construction-in-progress
Accrued Construction-In-Progress
Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction-in-progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accounting Standards Update [Extensible Enumeration]
Accounting Standards Update [Extensible Enumeration]